Alerts will be sent to your verified email
Verify Email
PARNAXLAB
|
Parnax Lab
|
Kimia Biosciences
|
Krebs Biochem.&Inds
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.43 % | -335.15 % | 37.05 % |
|
5yr average Equity Multiplier
|
2.74 | 66.02 | -2.13 |
|
5yr Average Asset Turnover Ratio
|
1.01 | 1.14 | 0.3 |
|
5yr Avg Net Profit Margin
|
4.21 % | -0.67 % | -55.19 % |
|
Price to Book
|
1.68 | 13.03 | 0.0 |
|
P/E
|
13.71 | 15.66 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
30.1 Days | -33.97 Days | -1144.52 Days |
|
Inventory Days
|
45.64 Days | 101.63 Days | 102.59 Days |
|
Days Receivable
|
61.56 Days | 98.68 Days | 8.23 Days |
|
Days Payable
|
72.37 Days | 171.28 Days | 623.06 Days |
|
5yr Average Interest Coverage Ratio
|
2.99 | 0.78 | -4.97 |
|
5yr Avg ROCE
|
17.86 % | 10.6 % | -23.43 % |
|
5yr Avg Operating Profit Margin
|
13.13 % | 3.89 % | -34.39 % |
|
5 yr average Debt to Equity
|
1.12 | 29.85 | -1.88 |
|
5yr CAGR Net Profit
|
n/a | 13.51 % | -0.84 % |
|
5yr Average Return on Assets
|
4.42 % | -0.69 % | -16.47 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.3 % | 74.94 % | 72.74 % |
|
Share Pledged by Promoters
|
9.41 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Parnax Lab
|
Kimia Biosciences
|
Krebs Biochem.&Inds
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|